Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996–2002: Table 1

2008 ◽  
Vol 67 (4) ◽  
pp. 574-575 ◽  
Author(s):  
L J Herrinton ◽  
L Liu ◽  
S Shoor ◽  
D Mines
Keyword(s):  
Rheumatoid Arthritis ◽  
Severe Rheumatoid Arthritis ◽  
Lymphoproliferative Cancer

PMS7 Adverse Event-Related Costs Associated with Abatacept and Upadacitinib for Moderate-to-Severe Rheumatoid Arthritis

2021 ◽  
Vol 24 ◽  
pp. S139
Author(s):  
X. Han ◽  
S(H Park ◽  
J.K. Schmier ◽  
N. Ning ◽  
D. Patel ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Adverse Event ◽  
Severe Rheumatoid Arthritis

scholarly journals Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis

2018 ◽  
Vol 4 (4) ◽  
pp. FSO289 ◽  
Author(s):  
Enrique R Soriano ◽  
Analia Dellepiane ◽  
Gabriela Salvatierra ◽  
Cristian Alejandro Benítez ◽  
Rodrigo Garcia Salinas ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Certolizumab Pegol ◽  
Heterogeneous Population ◽  
Severe Rheumatoid Arthritis

Safety of Baricitinib 4 mg for the Treatment of Moderate to Severe Rheumatoid Arthritis

2021 ◽  
Vol 114 (5) ◽  
pp. 288-292
Author(s):  
Tracey D. Dabal ◽  
Matthew B. Haltom ◽  
Puja P. Patel ◽  
Christine K. Son ◽  
Kiran P. Joglekar ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Severe Rheumatoid Arthritis
Sign in / Sign up

Export Citation Format

Share Document